Skip to main content

Want a detailed portfolio tracker?

Olema Pharmaceuticals (OLMA) Income Statement (2020 - 2026)

Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Olema Pharmaceuticals (OLMA).

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Reported currency: USD
Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020
Operating Expenses
Research And Development
49M
(+13.91%)
43M
(+8.19%)
40M
(-9.00%)
44M
(+43.37%)
31M
(-5.20%)
32M
(-2.80%)
33M
(+14.15%)
29M
(-2.58%)
30M
(+15.50%)
26M
(+33.01%)
19M
(+8.12%)
18M
(-21.20%)
23M
(+5.79%)
22M
(+22.40%)
18M
(-34.82%)
27M
(+68.96%)
16M
(+0.19%)
16M
(+27.64%)
13M
(+5.12%)
12M
(+11.41%)
11M
(+69.95%)
6.29M
(+34.69%)
4.67M
(+139.49%)
1.95M
(+143.75%)
800K
Selling General And Administrative
8.75M
(+27.55%)
6.86M
(+15.68%)
5.93M
(+49.75%)
3.96M
(-6.82%)
4.25M
(-4.92%)
4.47M
(+1.82%)
4.39M
(-0.68%)
4.42M
(-0.90%)
4.46M
(-1.76%)
4.54M
(+16.71%)
3.89M
(+7.76%)
3.61M
(-46.76%)
6.78M
(+20.21%)
5.64M
(+0.71%)
5.60M
(-10.26%)
6.24M
(-13.93%)
7.25M
(+25.43%)
5.78M
(+10.31%)
5.24M
(+13.67%)
4.61M
(-3.15%)
4.76M
(+23.96%)
3.84M
(+20.00%)
3.20M
(+492.59%)
540K
(+116.00%)
250K
Operating Expenses
58M
(+15.79%)
50M
(+9.15%)
46M
(-4.14%)
48M
(+37.25%)
35M
(-5.17%)
37M
(-2.26%)
38M
(+12.20%)
34M
(-2.36%)
34M
(+12.89%)
30M
(+30.33%)
23M
(+8.06%)
22M
(-27.03%)
30M
(+8.74%)
27M
(+17.23%)
23M
(-30.25%)
33M
(+43.18%)
23M
(+6.85%)
22M
(+22.52%)
18M
(+7.51%)
17M
(+6.93%)
15M
(+52.52%)
10M
(+28.72%)
7.87M
(+216.06%)
2.49M
(+139.42%)
1.04M
Depreciation And Amortization
120K
(-66.67%)
360K--130K
(-58.06%)
310K--90K
(-67.86%)
280K--100K
(-62.96%)
270K--80K
(-46.67%)
150K--10K
(0.00%)
10K---
Operating Income
Operating Income
-57.99M
(+15.79%)
-50.08M
(+9.15%)
-45.88M
(-4.14%)
-47.86M
(+37.25%)
-34.87M
(-5.17%)
-36.77M
(-2.26%)
-37.62M
(+12.20%)
-33.53M
(-2.36%)
-34.34M
(+12.89%)
-30.42M
(+30.33%)
-23.34M
(+8.06%)
-21.60M
(-27.03%)
-29.60M
(+8.74%)
-27.22M
(+17.23%)
-23.22M
(-30.25%)
-33.29M
(+43.18%)
-23.25M
(+6.85%)
-21.76M
(+22.52%)
-17.76M
(+7.51%)
-16.52M
(+6.93%)
-15.45M
(+52.52%)
-10.13M
(+28.72%)
-7.87M
(+216.06%)
-2.49M
(+139.42%)
-1.04M
Ebit
-57.99M
(+15.79%)
-50.08M
(+9.15%)
-45.88M
(-4.14%)
-47.86M
(+37.25%)
-34.87M
(-5.17%)
-36.77M
(-2.26%)
-37.62M
(+12.20%)
-33.53M
(-2.36%)
-34.34M
(+12.89%)
-30.42M
(+30.33%)
-23.34M
(+8.06%)
-21.60M
(-27.03%)
-29.60M
(+8.74%)
-27.22M
(+17.23%)
-23.22M
(-30.25%)
-33.29M
(+43.18%)
-23.25M
(+6.85%)
-21.76M
(+22.52%)
-17.76M
(+7.51%)
-16.52M
(+6.93%)
-15.45M
(+52.52%)
-10.13M
(+28.72%)
-7.87M
(+216.06%)
-2.49M
(+139.42%)
-1.04M
EBITDA
-57.87M
(+0.71%)
-57.46M
(+36.10%)
-42.22M
(-3.56%)
-43.78M
(+26.02%)
-34.74M
(-18.60%)
-42.68M
(+23.53%)
-34.55M
(+13.73%)
-30.38M
(-11.30%)
-34.25M
(+2.30%)
-33.48M
(+55.72%)
-21.50M
(+7.02%)
-20.09M
(-31.90%)
-29.50M
(+5.81%)
-27.88M
(+22.71%)
-22.72M
(-30.86%)
-32.86M
(+41.82%)
-23.17M
(+6.43%)
-21.77M
(+22.92%)
-17.71M
(+7.92%)
-16.41M
(+6.28%)
-15.44M
(+51.67%)
-10.18M
(+29.85%)
-7.84M
(+220.00%)
-2.45M
(+135.58%)
-1.04M
Other Income / Expenses
Interest Income
4.78M
(+19.20%)
4.01M
(+9.86%)
3.65M
(-9.65%)
4.04M
(-10.62%)
4.52M
(+37.39%)
3.29M
(+12.29%)
2.93M
(-5.79%)
3.11M
(-7.16%)
3.35M
(-5.63%)
3.55M
(+84.90%)
1.92M
(+23.87%)
1.55M
(+18.32%)
1.31M
(+35.05%)
970K
(+56.45%)
620K
(+47.62%)
420K
(+90.91%)
220K
(+100.00%)
110K
(0.00%)
110K
(-8.33%)
120K
(+9.09%)
110K-20K
(-33.33%)
30K-
Interest Expense
------------------------650K
Net Interest Income
4.78M
(+19.20%)
4.01M
(+9.86%)
3.65M
(-9.65%)
4.04M
(-10.62%)
4.52M
(+37.39%)
3.29M
(+12.29%)
2.93M
(-5.79%)
3.11M
(-7.16%)
3.35M
(-5.63%)
3.55M
(+84.90%)
1.92M
(+23.87%)
1.55M
(+18.32%)
1.31M
(+35.05%)
970K
(+56.45%)
620K
(+47.62%)
420K
(+90.91%)
220K
(+100.00%)
110K
(0.00%)
110K
(-8.33%)
120K
(+9.09%)
110K-20K
(-33.33%)
30K-650.00K
Other Non Operating Income
120K
(+500.00%)
20K
(+100.00%)
10K
(-75.00%)
40K-40.00K100K
(-28.57%)
140K
(+250.00%)
40K
(+100.00%)
20K-20.00K
(-75.00%)
-80.00K
(+100.00%)
-40.00K10K-30.00K
(-75.00%)
-120.00K20K
(+100.00%)
10K-50.00K
(-16.67%)
-60.00K-110K-590.00K-30K-650.00K
Net Income
Income Before Tax
--162.45M----129.47M-------------------
Net Income From Continuing Operations
-53.09M
(+15.26%)
-46.06M
(+9.10%)
-42.22M
(-3.56%)
-43.78M
(+44.06%)
-30.39M
(-9.47%)
-33.57M
(-2.84%)
-34.55M
(+13.73%)
-30.38M
(-1.91%)
-30.97M
(+15.69%)
-26.77M
(+24.51%)
-21.50M
(+7.02%)
-20.09M
(-28.99%)
-28.29M
(+8.06%)
-26.18M
(+15.23%)
-22.72M
(-30.86%)
-32.86M
(+42.68%)
-23.03M
(+6.42%)
-21.64M
(+22.19%)
-17.71M
(+7.92%)
-16.41M
(+6.98%)
-15.34M
(+51.43%)
-10.13M
(+29.21%)
-7.84M
(+220.00%)
-2.45M
(+44.97%)
-1.69M
Net Income
-53.09M
(+15.26%)
-46.06M
(+9.10%)
-42.22M
(-3.56%)
-43.78M
(+44.06%)
-30.39M
(-9.47%)
-33.57M
(-2.84%)
-34.55M
(+13.73%)
-30.38M
(-1.91%)
-30.97M
(+15.69%)
-26.77M
(+24.51%)
-21.50M
(+7.02%)
-20.09M
(-28.99%)
-28.29M
(+8.06%)
-26.18M
(+15.23%)
-22.72M
(-30.86%)
-32.86M
(+42.68%)
-23.03M
(+6.42%)
-21.64M
(+22.19%)
-17.71M
(+7.92%)
-16.41M
(+6.98%)
-15.34M
(+51.43%)
-10.13M
(+29.21%)
-7.84M
(+220.00%)
-2.45M
(+44.97%)
-1.69M
Comprehensive Income Net Of Tax
-54.17M
(-66.56%)
-161.97M
(+285.64%)
-42.00M
(-4.31%)
-43.89M
(+45.77%)
-30.11M
(-76.78%)
-129.68M
(+281.75%)
-33.97M
(+11.41%)
-30.49M
(-2.68%)
-31.33M
(-66.84%)
-94.49M
(+345.29%)
-21.22M
(+8.04%)
-19.64M
(-28.45%)
-27.45M
(-74.21%)
-106.45M
(+362.83%)
-23.00M
(-31.61%)
-33.63M
(+37.21%)
-24.51M
(-65.60%)
-71.24M
(+302.94%)
-17.68M
(+7.74%)
-16.41M
(+6.91%)
-15.35M
(-30.61%)
-22.12M
(+182.14%)
-7.84M
(+220.00%)
-2.45M
(+44.97%)
-1.69M